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Abstract
Background: In the present work we determined phenolic and flavonoids content of  Eriobotrya japonica leaves extracts 
and fractions and their antioxidant and anti-inflammatory properties.
Objectives: To evaluate the inhibition of  inflammatory PLA2 and antioxidant effects of  extracts and fractions from Erio-
botrya japonica leaves
Methods: Antioxidant activity was evaluated with DPPH radical scavenging assay and anti-inflammatory effect of  fractions 
was measured by their inhibition potency on the human pro-inflammatory phospholipase A2 (group IIA). 
Results: The EtOH/EtOAc 2:1 extract exhibited a potent inhibition of  the hG-IIA with an IC50 values of  8 µg/ml. It also 
shows an antioxidant activity measured on DPPH with an IC50 of  42 µg/ml. Fractionation shows that CH2Cl2/MeOH 0:1 
fraction was the rich one on flavonoids compounds (4.3 mg/g dry weight) and demonstrates a high antioxidant activity with 
an IC50 of  12 µg/ml. The anti-inflammatory evaluation demonstrates that the same fraction was the best one to inhibit the 
pro-inflammatory phospholipase A2 group IIA with an IC50 of  4 µg/ml.
Conclusion: Study conducted on Eriobotrya japonica shows that CH2Cl2/MeOH 0:1 fraction inhibits efficiently the hG-
IIA phospholipase.which is considered as pro-inflammatory enzyme.
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Introduction
Eriobotrya japonica Lindl, also known as ‘loquat’, be-
longs to the Rosaceae family. This plant is an evergreen 
shrub or small tree with narrow leaves that are dark 
green on the upper surface and have a lighter color un-
der surface. It is originated from south-eastern China 
and later became naturalized in Korea, Japan, India and 
many other countries.
Leaves of  Eriobotrya japonica (LEJ) Lindl (Rosaceae) 
have been used as traditional medicines for lung and 
stomach diseases and have been found to be effective 
in chronic bronchitis, inflammation, asthma, low back 
pain and tumor.1–3,4 Studies have demonstrated that 
LEJ has anti-inflammatory activity in a 12-O-tetrade-
canoylphorbol-13-acetate induced inflammation model. 
These reports strongly suggest that LEJ can be used as 
an anti-inflammatory agent. 
Various triterpenes, sesquiterpenes, flavonoids, tannins 
and megastigmane glycosides have been found in the 
LEJ and previous studies showed that some of  these 
components have anti-tumor, antiviral, hypoglycemic, 
antioxidant and anti-inflammatory properties3,5–8.
During the inflammatory process, macrophages pro-
duce nitric oxide, cytokine and pro-inflammatory en-
zymes such as secreted phospholipase A2 (sPLA2)9,10 
that catalyze the hydrolysis of  membrane phospholip-
ids to produce free arachidonic acid and lysophospho-
lipids. Indeed, several studies showed that sPLA2 are 
the chief  actors on the biosynthesis of  lipid mediators 
in inflammatory cells11. sPLA2 enzymes are a heter-
ogenic family that are divided on 11 groups (IB, IIA, 
IIC, IID, IIE, IIF, III, V, X, XIIA and XIIB)12–14. The 
sPLA2 group IIA was initially detected in synovial fluid 
of  patients with rheumatoid arthritis15,16. Several studies 
demonstrated that the sPLA2 group IIA was involved 
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in inflammatory process17–19 and many phospholipases 
A2 inhibitors have been discovered and their effective-
ness have been proved as a treatment of  inflammatory 
diseases20–22.
Because overproduction of  these inflammatory media-
tors might cause inflammatory damage, we focused in 
the present study on the evaluation of  the anti-inflam-
matory effect of  LEJ extracts by measuring the inhibi-
tion of  the pro-inflammatory sPLA2 group IIA as well 
as their antioxidant activity.
Material and methods
Plant material
Leaves of  Eriobotrya Japonica (Rosaceae) (LEJ) were 
collected in the region from Sfax (Tunisia) in June 2010. 
The plant was identified by Pr. M. Chaieb (Faculty of  
Sciences, Sfax University, Tunisia) and a voucher speci-
men has been deposited in the Chemical Laboratory of  
Narural Products (Sfax, Tunisia: No. LCSN 108)
Extraction and fractionation of  flavonoids
The dry leaves of  plant sample were ground to fine 
powder in a mill, and 100 g of  powder was extracted in 
1 L of  MeOH/H2O 7:3. After filtration, the methanol 
was removed by evaporation and 250 mL of  n-butanol 
was added. The organic phase was evaporated and the 
extract was dissolved in 200 mL of  EtOH/EtOAc 2:1. 
The issue sample was separated on four fractions using 
CH2Cl2/MeOH at 8:2, 7:3, 5:5 and 0:1 proportion, re-
spectively.
Total phenols determination
Total phenols determination of  the fractions of  Erio-
botrya japonica leaves extracts was determined by col-
orimetric assay according to the method described by 
23. 1 ml of  sample at 1 mg/ml was mixed with 1 ml of  
Folin-Ciocalteu reagent. After 3 min of  incubation, 1 
ml of  saturated Na2CO3 solution was added and the 
volume was adjusted to 10 ml with distilled water. The 
reaction mixture was kept in the dark for 90 min, after 
which the absorbance was read at 725 nm. The total 
phenolic content was determined using gallic acid as a 
standard.
Determination of  flavonoids content
Total flavonoids were determined by following the pro-
cedure24. Briefly, 1 mL of  aliquots of  leaves extracts and 
fractions were placed in two test tubes, respectively. 7 
mL of  methanol were added to one tube. In the other 
one, 1 mL of  2 % ZrOCl2-8H2O and 6 mL of  meth-
anol were added. The solution was mixed again and 
placed into water bath at 30 °C for 1 h. The absorbance 
was measured at 420 nm and ΔOD was calculated. The 
amount of  total flavonoids was calculated as a querci-
tin equivalent from the standard curve (figure 1), and 
expressed as mg quercitin/g dry leaves plant material 
(mg/g dry weight).
DPPH radical scavenging assay
The antioxidant activity of  LEJ extract and fractions 
were measured as equivalent of  hydrogen-donating or 
radical scavenging ability, using the DPPH method25–27 
with some modifications. Briefly, 1.5 mL of  DPPH 
solution at 10-5 M was incubated with 1.5 mL of  ex-
tracts containing variable amounts of  dry weight (be-
tween 0.01 and 1 mg). The reaction mixture was shaken 
and incubated in the dark for 30 min at room temper-
ature. Control experiment was performed as described 
above without adding any LEJ extract. The OD of  the 
solution was measured at 517 nm. The radical scaveng-
ing activity was calculated using the following equation:
Scavenging effect (%) =  
 
The extract concentration providing 50% inhibition 
(IC50) was calculated from the plot of  the scavenging 
effect (percentage) against the extract concentration. 
BHT was used as standard.
Anti-inflammatory activity
The anti-inflammatory activity of  extracts was followed 
by the inhibition of  the human inflammatory phospho-
lipase A2 group IIA (hG-IIA). The hG-IIA activity was 
measured as described by28. Briefly, the substrate con-
sisted of  3.5 mM lecithin (Sigma Aldrich) in a mixture 
of  3 mM NaTDC, 100 mM NaCl, 10 mM CaCl2 and 
0.055 mM red phenol as colorimetric indicator in 100 
mL H2O. The pH of  the reaction mixture was adjusted 
to 7.6. The hG-IIA or the pig pancreatic phospholipase 
A2 group IB (pG-IB) phospholipases were solubilized 
in 10% acetonitrile at a concentration of  0.02 and 0.002 
μg/μl, respectively. A volume of  10 μl of  these PLA2 
solutions was incubated for 20 min at room temperature 
with 10 μl of  each LEJ extracts and fractions. Then, 1 
mL of  the PLA2 substrate was injected in the medium, 
and the kinetic of  hydrolysis was followed during 5 min 
by reading the decrease of  OD at 558 nm. The inhi-
bition percentage was calculated by comparison with 
a control experiment and the IC50 values were deter-
mined from the blot. The control experiment contained 
10 µl of  the enzyme (hG-IIA or pG-IB) and 10 µl of  
the corresponding organic solvent.
Statistical analysis study
Experimental results were given as mean value ± SD of  
three separate experiments. Statistical analysis was con-
ducted using Microsoft Excel software using the Dun-
can test performed after analysis of  variance (ANOVA).
Results 
Extraction yields of  plant material
Dried and powdered LEJ were extracted with MeOH/
H2O 7:3 and then fractionated after that with butanol, 
EtOH/EtOAc 2:1 and CH2Cl2/MeOH at different 
percentage. Table 1 summarizes the extraction yield of  
LEJ.
Table 1. Extraction yields of LEJ  1 
Solvents Yields (g/100 g dry weight) 
Methanol/water (70/30) 15 
Butanol 12 
Ethanol-Ethyl acetate (2/1) 9 
CH2Cl2-MeOH (8/2) 1.2 
CH2Cl2-MeOH (7/3) 2.4 
CH2Cl2-MeOH (5/5) 3.1 
Methanol 2.3 
 2 
Total phenolic and flavonoids content 
Total phenolic content, expressed as mg GAEs/g DW 
and flavonoids content, expressed as mg quercitin/g 
DW of  LEJ extracts were presented in Table 2. Results 
show that phenolic and flavonoids content in EtOH/
EtOAc 2:1 extract were about 28 mg GAEs/g DW and 
7 mg EQ/g DW, respectively. These concentrations 
were lower than those from E. japonica cv. Zaozhong 
No. 6 and E. japonica Lindl29. These studies show that 
the two species contain 47.5 and 54.9 mg GAEs/g DW 
as phenolic content and 109.3 and 119 mg QE/g DW as 
flavonoids content, respectively. Therefore, the EtOH/
EtOAc 2:1 extract of  LEJ was further fractionated into 
CH2Cl2/MeOH (8:2, 7:3, 5:5 and 0:1) soluble fractions. 
Results reported in Table 2 show that CH2Cl2/MeOH 
(0:1) extract was the richest on phenolic and flavonoids 
compound with 13 mg GAEs/g DW and 4.3 mg QE/g 
DW, respectively.
Table 2. Phenolic and Flavonoids content in each fraction and their antioxidant activity.  1 
 Component (mg/g dry weight)  
Fractions Phenolic Flavonoids IC50 on DPPH radical (µg/mL) 
Ethanol-ethyl acetate (2/1) 28 ± 1.3 7 ± 0.52 42 ± 2.1 
CH2Cl2-MeOH (8/2) 2 ± 0.04 0.4 ± 0.03 83 ± 3.0 
CH2Cl2-MeOH (7/3) 5 ± 0.07 0.8 ± 0.03 67 ± 2.4 
CH2Cl2-MeOH (5/5) 8 ± 0.09 1.4 ± 0.08 35 ± 1.7 
CH2Cl2-MeOH (0/1) 13 ± 0.4 4.3 ± 0.1 12 ± 0.8 
BHT - - 69 ± 3.2 
 2 
DPPH radical scavenging activity
The antiradical activities of  the extracts were deter-
mined using the DPPH free radical assay (figure 2) 
and the radical scavenging activities were expressed 
as the mean of  the IC50 values (µg/mL). IC50 values 
and BHT were reported in Table 2. Our results show 
that the EtOH/EtOAc 2:1 extracts exhibit a capacity 
to reduce the DPPH with an IC50 of  42 µg/mL. Us-
ing this extract, the most potent fraction obtained with 
CH2Cl2/MeOH 0:1 shows an IC50 value about 12 µg/
mL, being 3.5 times more active than the initial extract. 
This result shows that there is correlation between the 
enrichment of  phenolic and flavonoids compounds and 
the antiradical activity. Consequently, we can hypothe-
size that phenolic or flavonoids compounds might be 
responsible for the antiradical activity.
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Figure 2: Radical scavenging activities of LEJ extracts and fractions measured  1 
on DPPH. 2 
 3 
 4 
Evaluation of  the anti-inflammatory effect
To evaluate the anti-inflammatory effect, we measured 
the ability of  these extracts and fractions to inhibit the 
inflammatory hG-IIA (figure 3A, 3B) and the digestive 
pG-IB (figure 3C) phospholipases A2.
Figure 3: Inhibitory effect of LEJ extracts and fractions on PLA2. A and B: pro-1 








Results show that the EtOH/EtOAc 2:1 extract in-
hibits the hG-IIA PLA2 and the pG-IB with an IC50 
of  8 µg/mL and 1200 µg/mL, respectively (Table 3). 
This finding proves that this extract inhibits preferen-
tially hG-IIA with a relative specificity inhibition factor 
of  about 150. Fractions from this extract were tested 
for their ability to inhibit these two PLA2 and results 
revealed that CH2Cl2/MeOH 0:1 fraction is the most 
interesting one (Table 3). 
Table 3. Inhibitory effect of LEJ extracts on hG-IIA and pG-IB phospholipases. 1 
Fractions  IC50 values on  hG-IIA (µg/mL) 
IC50 values on 
pG-IB (µg/mL) 
Inhibition specificity 
(IC50 pG-IB /IC50 hG-IIA) 
Ethanol-ethyl acetate (2/1) 8 ± 0.4 1200 ± 50 150 
CH2Cl2-MeOH (8/2) 2300 ± 100 > 5000 > 2.17 
CH2Cl2-MeOH (7/3) 3500 ± 120 > 5000 > 1.42 
CH2Cl2-MeOH (5/5) 1000 ± 40 > 5000 > 5 
CH2Cl2-MeOH (0/1) 4 ± 0.3 800 ± 20 200 
 2 
In fact, this fraction inhibits preferentially the hG-IIA 
enzyme with an IC50 of  4 µg/mL versus 800 µg/mL 
measured on pG-IB PLA2. To highlight the specifici-
ty inhibition of  hG-IIA versus pG-IB, we calculate the 
specificity factor 
which is around 200. This value indicates that the in-
hibitory potency of  this fraction toward hG-IIA is 
200 times higher than its toward pG-IB. This fraction 
was likely able to inhibit preferentially the inflammato-
ry PLA2 (hG-IIA) and not the digestive one (pG-IB). 
Moreover, we can strongly suggest that phenolic or 
flavonoid compounds in CH2Cl2/MeOH 0:1 were re-
sponsible for the hG-IIA inhibition.





In this study, we targeted the extraction of  phenolic 
and flavonoids compounds present in LEJ. In fact, sev-
eral previous works described the importance of  the 
biological functions of  these molecules such as antiox-
idant24,30–32, anti-inflammatory33,34, anti-atherosclerot-
ic35,36, anticancer35,37,38 and antimicrobial activities39,40. 
Indeed, the ethanol-ethyl acetate (2/1) extract contains 
28 mg GAE/g DW of  phenolic compounds and 7 mg 
EQ/g DW of  flavonoid contents and show an impor-
  1 
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tant antioxidant activity measured on DPPH with an 
IC50 of  42 µg/mL. These results are in agreement with 
those obtained by41 and24 who reported that there is a 
close relationship between phenolic and flavonoid con-
tent and the antioxidant activity in Eriobotrya japonica 
extracts.
On the purpose to identify natural anti-inflammato-
ry compounds, several studies were performed using 
Eriobotrya japonica due to its well known potent an-
ti-inflammatory effects42 and these have demonstrated 
that leaf  of  Eriobotrya japonica was able to suppress 
LPS-induced cytokine production in a dose dependent 
manner. Moreover,8 they have proved that water extract 
of  Eriobotrya japonica leaves regulates production of  
pro-inflammatory cytokines such as TNFα, IL6 and 
IL8 in mast cells. We also reported in this study that 
the ethanol-ethyl acetate (2/1) extract of  Eriobotrya ja-
ponica inhibits the pro-inflammatory PLA2 (hG-IIA) 
with an IC50 of  8 µg/mL. The selective inhibition was 
performed using the digestive PLA2 (pG-IB) and our 
results reveal that the EtOH/EtOAc 2:1 extract inhibits 
the pancreatic enzyme with an IC50 of  1200 µg/mL. 
This result confirms that the extract inhibits preferen-
tially the pro-inflammatory PLA2 with a relative selec-
tivity factor of  150. These results have encouraged us 
to split over this extract. On this purpose, liquid-liquid 
extraction was performed using CH2Cl2/MeOH at var-
ious percentages. Obtained fractions were evaluated for 
their phenolic and flavonoids content and their ability 
to possess antioxidant and anti-inflammatory activities. 
Results presented in Table 2 show that CH2Cl2/MeOH 
0:1 fraction was the richest on phenolic and flavonoids 
content with values of  13mg EAG/g DW and 4.3 mg 
EQ/g DW, respectively, and with the most antioxidant 
effect (IC50 = 12 µg/mL). In the same way, this fraction 
has demonstrated the best capacity to inhibit hG-IIA 
versus pG-IB with IC50 values of  4 µg/mL and 800 
µg/mL, respectively. These results suggest that the phe-
nolic and flavonoids compounds in CH2Cl2/MeOH 0:1 
are responsible for preferential inhibition of  hG-IIA 
compared to the digestive pG-IB one.
Several studies investigated medicinal plants for their 
potent natural therapeutic virtues and only few of  them 
were described for their capacity to inhibit the inflam-
matory PLA2 enzyme. The ethanol extract of  the stem 
of  Sinomenium acutum, Spatholobus suberectus and 
Trachelosermum jasminoide show IC50 values of  112, 
54 and 33 µg/mL, respectively43. Compared to these 
works, the fractions that we obtained are more efficient 
to inhibit the pro-inflammatory PLA2 with an IC50 of  
4 µg/ml.
Conclusion
The aim of  the present study was to evaluate the anti-in-
flammatory and the antioxidant activities of  phenolic 
and flavonoids content in Eriobotrya japonica leaves. 
To that end, we performed fractionation of  EtOH/
EtOAc 2:1 using CH2Cl2/MeOH in different propor-
tions. The evaluation of  these fractions shows that a 
correlation may exist between phenolic and flavonoids 
compounds and the anti-inflammatory and the antiox-
idant activities.
So far we are using extract from LEJ and its fraction; 
the compound responsible for the preferential inhibi-
tion of  the hG-IIA PLA2 is still not identified. The ef-
forts in purification and identification of  active compo-
nents from LEJ are ongoing.
Abbreviations: IC50: inhibitory concentration at 50 %, 
sPLA2: secreted phospholipase A2, hG-IIA: human 
secreted phospholipase A2 group IIA, pG-IB: pig se-
creted phospholipase A2 group IB, LEJ: leaves of  Eri-
obotrya japonica, DPPH: 2,2-diphényl 1-picrylhydra-
zyl, CH2Cl2: dichloromethane, MeOH: methanol, DW: 
dry weight, GAE: gallic acid equivalent, QE: quercitin 
equivalent, NaTDC: sodium taurodeoxycholate
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